Electrolyte disturbances can lead to flecainide toxicity and pacemaker malfunction despite normal serum flecainide levels.
Answers are grounded in this paper and cite their sources.
Electrolyte monitoring may be prudent in flecainide patients with pacemakers despite normal levels; hypothesis-generating for toxicity mechanisms.
Flecainide is a class Ic antiarrhythmic agent that depresses the rate of depolarization of action potentials by blocking sodium channels.1,2 It is used commonly in the treatment of supraventricular arrhythmias, atrial fibrillation, and atrial flutter, and less commonly in ventricular tachycardias, in patients with normal cardiac structure.3,4 Flecainide has a narrow therapeutic window. Severe effects in cases of toxicity and overdose include negative inotropy, bradyarrhythmias, atrioventricular nodal block, ventricular tachycardia or fibrillation, and asystole, with overdose mortality rate at approximately 22%.
No takes yet. Share an insight, caveat, or question.
Kasia et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: